Cardio-Renal Outcomes in Chronic Kidney Disease Study
Cardio-Renal Outcomes in Chronic Kidney Disease Trials in Phoenix
Aventiv Research is currently participating in an chronic kidney disease study to asses cardio-renal outcomes at our Phoenix, AZ location. Chronic kidney disease (CKD) describes the gradual loss of kidney function. Chronic kidney disease may not become apparent until your kidney function is significantly impaired. Treatment for chronic kidney disease focuses on slowing the progression of the kidney damage, usually by controlling the underlying cause. Advances in drug therapy are key to treating this disease at its early stages and preventing further damage.
Cardio-Renal Outcomes in Chronic Kidney Disease Clinical Trial
The objective of this study is to assess cardio-renal outcomes from an investigational drug versus placebo in patients with chronic kidney disease. You maybe be eligible to participate in this study if you are:
- At least 18 years of age
- Have progressive chronic kidney disease
and do NOT:
- Currently need an SGLT-2 or SGLT-1/2 inhibitor
Ready to Volunteer?
Volunteer today to see if you qualify for our chronic kidney disease study to asses cardio-renal outcomes. *Qualified volunteers may be compensated for time and travel.